Lurbinectedin
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Lurbinectedin
Jul 2, 2024, 14:57 |
Blog
Wafik S. El-Deiry: My second talk at the DAVA Oncology 3rd Global Thoracic Malignancies Summit
Wafik S. El-Deiry shared on LinkedIn: “Gave my second talk at the DAVA Oncology 3rd…
Jun 15, 2024, 05:45 |
Blog
Mohammad Jad Moussa: Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
Feb 10, 2024, 15:51 |
Drugs
Vivek Subbiah: Pleased to share my thoughts on Lurbinecredin data in small cell lung cancer
Vivek Subbiah shared a post on LinkedIn: “Pleased to share my thoughts on Lurbinecredin data…
Aug 28, 2023, 17:40 |
Insight
Vivek Subbiah: Lurbinectedin was approved for Small cell Lung in USA and now is also approved in Canada, Australia, Singapore, the United Arab Emirates, Qatar, South Korea, Ecuador, Mexico, Israel and Switzerland.
Aug 11, 2023, 17:44 |
Insight
Vivek Subbiah: Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin
Hot off the press Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin.…
All:
5
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube